David T. Teachey

David T. Teachey

University of Pennsylvania

H-index: 66

North America-United States

About David T. Teachey

David T. Teachey, With an exceptional h-index of 66 and a recent h-index of 53 (since 2020), a distinguished researcher at University of Pennsylvania, specializes in the field of Acute Lymphoblastic Leukemia, Hematologic malignancies, Immune Dysregulation, Immunotherapy, Autoimmune Lymphoproliferative Synd.

His recent articles reflect a diverse array of research interests and contributions to the field:

Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report

New Developments in the Treatment of Pediatric Acute Lymphoblastic Leukemia

Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders

How I treat early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) in children

Next-Generation Sequencing (NGS) for Residual Disease (MRD) Monitoring in T-Lymphoblastic Leukemia (T-ALL)

TORing the impact of sirolimus on immune health

Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children’s Oncology Group report

Dual targeting of apoptotic and signaling pathways in T-lineage acute lymphoblastic leukemia

David T. Teachey Information

University

Position

Associate Professor of Pediatrics

Citations(all)

27344

Citations(since 2020)

16643

Cited By

17536

hIndex(all)

66

hIndex(since 2020)

53

i10Index(all)

146

i10Index(since 2020)

133

Email

University Profile Page

University of Pennsylvania

Google Scholar

View Google Scholar Profile

David T. Teachey Skills & Research Interests

Acute Lymphoblastic Leukemia

Hematologic malignancies

Immune Dysregulation

Immunotherapy

Autoimmune Lymphoproliferative Synd

Top articles of David T. Teachey

Title

Journal

Author(s)

Publication Date

Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report

Leukemia

NJ DelRocco

ML Loh

MJ Borowitz

S Gupta

KR Rabin

...

2024/2/15

New Developments in the Treatment of Pediatric Acute Lymphoblastic Leukemia

Haley Newman

David T Teachey

2024/2/6

Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders

Aude Magerus

Anne Rensing-Ehl

V Koneti Rao

David T Teachey

Frederic Rieux-Laucat

...

2024/1/1

How I treat early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) in children

Ryan J Summers

David T Teachey

Stephen P Hunger

2024/2/18

Next-Generation Sequencing (NGS) for Residual Disease (MRD) Monitoring in T-Lymphoblastic Leukemia (T-ALL)

Blood

Ntasha Roy

Zhengwei Jenny Mao

Chang Xu

David T Teachey

Zhiguo Bruce Chen

...

2023/11/28

TORing the impact of sirolimus on immune health

Blood, The Journal of the American Society of Hematology

Kandace Gollomp

David T Teachey

2023/1/19

Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children’s Oncology Group report

Blood

Nathan P Gossai

Meenakshi Devidas

Zhiguo Chen

Brent L Wood

Patrick A Zweidler-McKay

...

2023/4/13

Dual targeting of apoptotic and signaling pathways in T-lineage acute lymphoblastic leukemia

Clinical Cancer Research

Caner Saygin

Giorgia Giordano

Kathryn Shimamoto

Bart Eisfelder

Anika Thomas-Toth

...

2023/8/15

Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome

Transplantation and Cellular Therapy

Melissa R Hines

Tristan E Knight

Kevin O McNerney

Mark B Leick

Tania Jain

...

2023/7/1

The genomic basis of childhood T-lineage acute lymphoblastic leukemia

Charles Mullighan

Petri Pölönen

Danika Di Giacomo

Anna Seffernick

Abdelrahman Elsayed

...

2023/10/27

Fratricide-Resistant Anti-CD2 Chimeric Antigen Receptor T-Cells with Endogenous CD2 Knockout Are Highly Effective Against T-Cell Neoplasms

Blood

Mathew G Angelos

Ruchi P Patel

Yi-Hao Chiang

Wei Xie

Raymone Pajarillo

...

2023/11/28

PI3king apart a rare disease with targeted therapy

Blood, The Journal of the American Society of Hematology

Haley Newman

David T Teachey

2023/3/2

Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young

medRxiv

Shunsuke Kimura

Petri Polonen

Lindsey Montefiori

Chun Shik Park

Ilaria Iacobucci

...

2023

Impact of vincristine-steroid pulses during maintenance for B-cell pediatric ALL: a systematic review and meta-analysis

Louise Guolla

Sara Breitbart

Farid Foroutan

Lehana Thabane

Mignon L Loh

...

2023/6/15

Flow cytometric assessment of leukemia-associated monocytes in childhood B-cell acute lymphoblastic leukemia outcome

Blood Advances

Gloria P Contreras Yametti

Nikki A Evensen

Jennifer M Schloss

Clemence Aldebert

Emily Duan

...

2023/8/8

Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients

Blood Advances

Matthew R Schuelke

Hamid Bassiri

Edward M Behrens

Scott Canna

Colleen Croy

...

2023/9/26

IL-10 Levels Differentially Regulate IFNg Signaling of CART19 and CART22

Blood

Caroline Diorio

Regina M Myers

Anastasia Frank-Kamenetski

Rawan Shraim

Amanda M Dinofia

...

2023/11/28

Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma

Yaya Chu

Aliza Gardenswartz

Caroline Diorio

Lianna J Marks

Eric Lowe

...

2023/3/1

Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia

Leukemia

Satoshi Yoshimura

John C Panetta

Jianzhong Hu

Lie Li

Yoshihiro Gocho

...

2023/6

P269: Essential role of genetic counseling in a multidisciplinary immune dysregulation program

Genetics in Medicine Open

Anna Platt

Hamid Bassiri

Edward Behrens

Scott Canna

Kandace Gollomp

...

2023/1/1

See List of Professors in David T. Teachey University(University of Pennsylvania)